+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Cancer Immunotherapy Market Analysis (2017-2023)

  • ID: 4456924
  • Report
  • December 2017
  • Region: Global
  • 220 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Amgen Inc.
  • Astrazeneca Plc.
  • Bayer AG
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
The Global Cancer Immunotherapy Market was valued at $45 billion in 2016, and is estimated to reach $119 billion by 2023, growing at a CAGR of 15% during the forecast period. Cancer immunotherapy is the type of cancer treatment helping the immune system fight cancer. There are various kinds of cancer immunotherapies used and they are monoclonal antibody, therapeutic cancer vaccines, checkpoint inhibitors, cytokines, and others. Growing patient population that is suffering from different types of cancer such as lung cancer, breast cancer, ovarian cancer, and other cancers are the factors that drive the global cancer immunotherapy market. Additionally, growing geriatric population and governmental contribution to healthcare expenditure are some other factors that add to the market growth.

The key factors driving the growth of cancer immunotherapy market are raising incidence and prevalence of cancer, technologically advanced treatment therapies, Growing R&D activities to treat cancer, and specificity & effectiveness of cancer immunotherapy for the treatment of wide range of cancers such as lung cancer, breast cancer, skin cancer, and others. Also, growing healthcare expenditure and better healthcare insurance coverage would further add to the market growth during the analysis period. Nevertheless, lack of professional healthcare experts and limited awareness about possible solutions among the population are the factors that limit the growth.

Based on Technology, the market report segments the market into Monoclonal Antibodies, Cytokines & Immunomodulators, and Other Technology. Based on end user is segmented into Polymeric Coatings and Organic Coatings. The Application covered under the report includes Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and Other Cancer. The report also covers geographical segmentation of Cancer Immunotherapy market. The report also covers geographical segmentation of Cancer Immunotherapy Market. The geographies included in the report are North America, Europe, Asia-Pacific, Middle East and Africa. For the better analysis, the geographies are segmented into countries.

The market research report covers the analysis of key stake holders of the Global Cancer Immunotherapy Market. Key companies profiled in the report include Novartis Ag, Astrazeneca Plc., Amgen Inc., Immunomedics, Inc., Bayer Ag, Pfizer Inc., Bristol-Myers Squibb, Merck Sharp & Dohme Corp., Eli Lilly And Company, and F. Hoffmann-La Roche Ltd.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen Inc.
  • Astrazeneca Plc.
  • Bayer AG
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Cancer Immunotherapy Market, by Technology
1.4.2 Global Cancer Immunotherapy Market, by Application
1.4.3 Global Cancer Immunotherapy Market, by End User
1.4.4 Global Cancer Immunotherapy Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.2 Drivers, Restraints and Opportunities
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Cancer Immunotherapy Market
3.1 Global Cancer Immunotherapy Market by Technology
3.1.1 Global Monoclonal Antibodies Cancer Immunotherapy Market by Region
3.1.2 Global Cytokines & Immunomodulators Cancer Immunotherapy Market by Region
3.1.3 Global Other Technology Cancer Immunotherapy Market by Region

Chapter 4. Global Cancer Immunotherapy Market by End User
4.1 Introduction
4.1.1 Global Hospitals Cancer Immunotherapy Market by Region
4.1.2 Global Clinics & Others Cancer Immunotherapy Market by Region

Chapter 5. Global Cancer Immunotherapy Market by Application
5.1 Introduction
5.1.1 Global Cancer Immunotherapy in Lung Cancer Market by Region
5.1.2 Global Cancer Immunotherapy in Breast Cancer Market by Region
5.1.3 Global Cancer Immunotherapy in Colorectal Cancer Market by Region
5.1.4 Global Cancer Immunotherapy in Melanoma Market by Region
5.1.5 Global Cancer Immunotherapy in Prostate Cancer Market by Region
5.1.6 Global Cancer Immunotherapy in Head & Neck Cancer Market by Region
5.1.7 Global Cancer Immunotherapy in Other Application Market by Region

Chapter 6. Global Cancer Immunotherapy Market by Region
6.1 Introduction
6.1.1 North America Cancer Immunotherapy Market
6.1.2 North America Cancer Immunotherapy Market by Technology
6.1.2.1 North America Monoclonal Antibodies Cancer Immunotherapy Market by Country
6.1.2.2 North America Cytokines & Immunomodulators Cancer Immunotherapy Market by Country
6.1.2.3 North America Other Technology Cancer Immunotherapy Market by Country
6.1.3 North America Cancer Immunotherapy Market by End User
6.1.3.1 North America Hospitals Cancer Immunotherapy Market by Country
6.1.3.2 North America Clinics & Others Cancer Immunotherapy Market by Country
6.1.4 North America Cancer Immunotherapy Market by Application
6.1.4.1 North America Cancer Immunotherapy in Lung Cancer Market by Country
6.1.4.2 North America Cancer Immunotherapy in Breast Cancer Market by Country
6.1.4.3 North America Cancer Immunotherapy in Colorectal Cancer Market by Country
6.1.4.4 North America Cancer Immunotherapy in Melanoma Market by Country
6.1.4.5 North America Cancer Immunotherapy in Prostate Cancer Market by Country
6.1.4.6 North America Cancer Immunotherapy in Head & Neck Cancer Market by Country
6.1.4.7 North America Cancer Immunotherapy in Other Application Market by Country
6.1.5 North America Cancer Immunotherapy Market by Country
6.1.6 US Cancer Immunotherapy Market
6.1.6.1 US Cancer Immunotherapy Market by Technology
6.1.6.2 US Cancer Immunotherapy Market by End User
6.1.6.3 US Cancer Immunotherapy Market by Application
6.1.7 Canada Cancer Immunotherapy Market
6.1.7.1 Canada Cancer Immunotherapy Market by Technology
6.1.7.2 Canada Cancer Immunotherapy Market by End User
6.1.7.3 Canada Cancer Immunotherapy Market by Application
6.1.8 Mexico Cancer Immunotherapy Market
6.1.8.1 Mexico Cancer Immunotherapy Market by Technology
6.1.8.2 Mexico Cancer Immunotherapy Market by End User
6.1.8.3 Mexico Cancer Immunotherapy Market by Application
6.1.9 Rest of North America Cancer Immunotherapy Market
6.1.9.1 Rest of North America Cancer Immunotherapy Market by Technology
6.1.9.2 Rest of North America Cancer Immunotherapy Market by End User
6.1.9.3 Rest of North America Cancer Immunotherapy Market by Application
6.1.10 Europe Cancer Immunotherapy Market
6.1.10.1 Europe Cancer Immunotherapy Market by Technology
6.1.10.1.1 Europe Monoclonal Antibodies Cancer Immunotherapy Market by Country
6.1.10.1.2 Europe Cytokines & Immunomodulators Cancer Immunotherapy Market by Country
6.1.10.1.3 Europe Other Technology Cancer Immunotherapy Market by Country
6.1.10.2 Europe Cancer Immunotherapy Market by End User
6.1.10.2.1 Europe Hospitals Cancer Immunotherapy Market by Country
6.1.10.2.2 Europe Clinics & Others Cancer Immunotherapy Market by Country
6.1.10.3 Europe Cancer Immunotherapy Market by Application
6.1.10.3.1 Europe Cancer Immunotherapy in Lung Cancer Market by Country
6.1.10.3.2 Europe Cancer Immunotherapy in Breast Cancer Market by Country
6.1.10.3.3 Europe Cancer Immunotherapy in Colorectal Cancer Market by Country
6.1.10.3.4 Europe Cancer Immunotherapy in Melanoma Market by Country
6.1.10.3.5 Europe Cancer Immunotherapy in Prostate Cancer Market by Country
6.1.10.3.6 Europe Cancer Immunotherapy in Head & Neck Cancer Market by Country
6.1.10.3.7 Europe Cancer Immunotherapy in Other Application Market by Country
6.1.11 Europe Cancer Immunotherapy Market by Country
6.1.11.1 Germany Cancer Immunotherapy Market
6.1.11.1.1 Germany Cancer Immunotherapy Market by Technology
6.1.11.1.2 Germany Cancer Immunotherapy Market by End User
6.1.11.1.3 Germany Cancer Immunotherapy Market by Application
6.1.11.2 UK Cancer Immunotherapy Market
6.1.11.2.1 UK Cancer Immunotherapy Market by Technology
6.1.11.2.2 UK Cancer Immunotherapy Market by End User
6.1.11.2.3 UK Cancer Immunotherapy Market by Application
6.1.11.3 France Cancer Immunotherapy Market
6.1.11.3.1 France Cancer Immunotherapy Market by Technology
6.1.11.3.2 France Cancer Immunotherapy Market by End User
6.1.11.3.3 France Cancer Immunotherapy Market by Application
6.1.11.4 Russia Cancer Immunotherapy Market
6.1.11.4.1 Russia Cancer Immunotherapy Market by Technology
6.1.11.4.2 Russia Cancer Immunotherapy Market by End User
6.1.11.4.3 Russia Cancer Immunotherapy Market by Application
6.1.11.5 Spain Cancer Immunotherapy Market
6.1.11.5.1 Spain Cancer Immunotherapy Market by Technology
6.1.11.5.2 Spain Cancer Immunotherapy Market by End User
6.1.11.5.3 Spain Cancer Immunotherapy Market by Application
6.1.11.6 Italy Cancer Immunotherapy Market
6.1.11.6.1 Italy Cancer Immunotherapy Market by Technology
6.1.11.6.2 Italy Cancer Immunotherapy Market by End User
6.1.11.6.3 Italy Cancer Immunotherapy Market by Application
6.1.11.7 Rest of Europe Cancer Immunotherapy Market
6.1.11.7.1 Rest of Europe Cancer Immunotherapy Market by Technology
6.1.11.7.2 Rest of Europe Cancer Immunotherapy Market by End User
6.1.11.7.3 Rest of Europe Cancer Immunotherapy Market by Application
6.2 Asia Pacific Cancer Immunotherapy Market
6.2.1 Asia Pacific Cancer Immunotherapy Market by Technology
6.2.1.1 Asia Pacific Monoclonal Antibodies Cancer Immunotherapy Market by Country
6.2.1.2 Asia Pacific Cytokines & Immunomodulators Cancer Immunotherapy Market by Country
6.2.1.3 Asia Pacific Other Technology Cancer Immunotherapy Market by Country
6.2.2 Asia Pacific Cancer Immunotherapy Market by End User
6.2.2.1 Asia Pacific Hospitals Cancer Immunotherapy Market by Country
6.2.2.2 Asia Pacific Clinics & Others Cancer Immunotherapy Market by Country
6.2.2.3 Asia Pacific Cancer Immunotherapy Market by Application
6.2.3 Asia Pacific Cancer Immunotherapy in Lung Cancer Market by Country
6.2.3.1 Asia Pacific Cancer Immunotherapy in Breast Cancer Market by Country
6.2.3.2 Asia Pacific Cancer Immunotherapy in Colorectal Cancer Market by Country
6.2.3.3 Asia Pacific Cancer Immunotherapy in Melanoma Market by Country
6.2.3.4 Asia Pacific Cancer Immunotherapy in Prostate Cancer Market by Country
6.2.3.5 Asia Pacific Cancer Immunotherapy in Head & Neck Cancer Market by Country
6.2.3.6 Asia Pacific Cancer Immunotherapy in Other Application Market by Country
6.2.3.7 Asia Pacific Cancer Immunotherapy Market by Country
6.2.3.8 China Cancer Immunotherapy Market
6.2.3.8.1 China Cancer Immunotherapy Market by Technology
6.2.3.8.2 China Cancer Immunotherapy Market by End User
6.2.3.8.3 China Cancer Immunotherapy Market by Application
6.2.3.9 Japan Cancer Immunotherapy Market
6.2.3.9.1 Japan Cancer Immunotherapy Market by Technology
6.2.3.9.2 Japan Cancer Immunotherapy Market by End User
6.2.3.9.3 Japan Cancer Immunotherapy Market by Application
6.2.3.10 India Cancer Immunotherapy Market
6.2.3.10.1 India Cancer Immunotherapy Market by Technology
6.2.3.10.2 India Cancer Immunotherapy Market by End User
6.2.3.10.3 India Cancer Immunotherapy Market by Application
6.2.3.11 South Korea Cancer Immunotherapy Market
6.2.3.11.1 South Korea Cancer Immunotherapy Market by Technology
6.2.3.11.2 South Korea Cancer Immunotherapy Market by End User
6.2.3.11.3 South Korea Cancer Immunotherapy Market by Application
6.2.3.12 Singapore Cancer Immunotherapy Market
6.2.3.12.1 Singapore Cancer Immunotherapy Market by Technology
6.2.3.12.2 Singapore Cancer Immunotherapy Market by End User
6.2.3.12.3 Singapore Cancer Immunotherapy Market by Application
6.2.3.13 Malaysia Cancer Immunotherapy Market
6.2.3.13.1 Malaysia Cancer Immunotherapy Market by Technology
6.2.3.13.2 Malaysia Cancer Immunotherapy Market by End User
6.2.3.13.3 Malaysia Cancer Immunotherapy Market by Application
6.2.3.14 Rest of Asia Pacific Cancer Immunotherapy Market
6.2.3.14.1 Rest of Asia Pacific Cancer Immunotherapy Market by Technology
6.2.3.14.2 Rest of Asia Pacific Cancer Immunotherapy Market by End User
6.2.3.14.3 Rest of Asia Pacific Cancer Immunotherapy Market by Application
6.3 LAMEA Cancer Immunotherapy Market
6.3.1 LAMEA Cancer Immunotherapy Market by Technology
6.3.1.1 LAMEA Monoclonal Antibodies Cancer Immunotherapy Market by Country
6.3.1.2 LAMEA Cytokines & Immunomodulators Cancer Immunotherapy Market by Country
6.3.1.3 LAMEA Other Technology Cancer Immunotherapy Market by Country
6.3.2 LAMEA Cancer Immunotherapy Market by End User
6.3.2.1 LAMEA Hospitals Cancer Immunotherapy Market by Country
6.3.2.2 LAMEA Clinics & Others Cancer Immunotherapy Market by Country
6.3.3 LAMEA Cancer Immunotherapy Market by Application
6.3.3.1 LAMEA Cancer Immunotherapy in Lung Cancer Market by Country
6.3.3.2 LAMEA Cancer Immunotherapy in Breast Cancer Market by Country
6.3.3.3 LAMEA Cancer Immunotherapy in Colorectal Cancer Market by Country
6.3.3.4 LAMEA Cancer Immunotherapy in Melanoma Market by Country
6.3.3.5 LAMEA Cancer Immunotherapy in Prostate Cancer Market by Country
6.3.3.6 LAMEA Cancer Immunotherapy in Head & Neck Cancer Market by Country
6.3.3.7 LAMEA Cancer Immunotherapy in Other Application Market by Country
6.3.4 LAMEA Cancer Immunotherapy Market by Country
6.3.4.1 Brazil Cancer Immunotherapy Market
6.3.4.1.1 Brazil Cancer Immunotherapy Market by Technology
6.3.4.1.2 Brazil Cancer Immunotherapy Market by End User
6.3.4.1.3 Brazil Cancer Immunotherapy Market by Application
6.3.5 Argentina Cancer Immunotherapy Market
6.3.5.1 Argentina Cancer Immunotherapy Market by Technology
6.3.5.2 Argentina Cancer Immunotherapy Market by End User
6.3.5.3 Argentina Cancer Immunotherapy Market by Application
6.3.6 UAE Cancer Immunotherapy Market
6.3.6.1 UAE Cancer Immunotherapy Market by Technology
6.3.6.2 UAE Cancer Immunotherapy Market by End User
6.3.6.3 UAE Cancer Immunotherapy Market by Application
6.3.7 Saudi Arabia Cancer Immunotherapy Market
6.3.7.1 Saudi Arabia Cancer Immunotherapy Market by Technology
6.3.7.2 Saudi Arabia Cancer Immunotherapy Market by End User
6.3.7.3 Saudi Arabia Cancer Immunotherapy Market by Application
6.3.8 South Africa Cancer Immunotherapy Market
6.3.8.1 South Africa Cancer Immunotherapy Market by Technology
6.3.8.2 South Africa Cancer Immunotherapy Market by End User
6.3.8.3 South Africa Cancer Immunotherapy Market by Application
6.3.9 Nigeria Cancer Immunotherapy Market
6.3.9.1 Nigeria Cancer Immunotherapy Market by Technology
6.3.9.2 Nigeria Cancer Immunotherapy Market by End User
6.3.9.3 Nigeria Cancer Immunotherapy Market by Application
6.3.10 Rest of LAMEA Cancer Immunotherapy Market
6.3.10.1 Rest of LAMEA Cancer Immunotherapy Market by Technology
6.3.10.2 Rest of LAMEA Cancer Immunotherapy Market by End User
6.3.10.3 Rest of LAMEA Cancer Immunotherapy Market by Application

Chapter 7. Company Profiles
7.1 Novartis AG
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Astrazeneca Plc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.3 Amgen Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Immunomedics, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Research & Development Expense
7.5 Bayer AG
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 Pfizer Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 Bristol-Myers Squibb
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 Merck Sharp & Dohme Corp.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Eli Lilly and Company
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.1 F. Hoffmann-La Roche Ltd
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
Note: Product cover images may vary from those shown
  • Novartis AG
  • Astrazeneca Plc.
  • Amgen Inc.
  • Immunomedics, Inc.
  • Bayer AG
  • Pfizer Inc.
  • Bristol-Myers Squibb
  • Merck Sharp & Dohme Corp.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll